Analysts estimate that QuantumScape will report an earnings per share (EPS) of $-0.19. QuantumScape bulls will hope to hear the company announce they've not only beaten that estimate, but also to ...

Valued at a market cap of $117.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that ...

Explore why QuantumScape Corporation's recent drop may present a buying opportunity ahead of Q2 earnings. Click for my ...

QuantumScape shares are trading higher Tuesday afternoon. The stock is rebounding ahead of its Q2 earnings report, scheduled ...

We recently published 10 Big Names Get Slammed. QuantumScape Corporation (NYSE:QS) is one of the biggest losers on Monday.

Despite its promise, QuantumScape faces substantial risks. The company is pre-revenue, with no commercial contracts, raising doubts about its ability to deliver. Its cash burn is significant, with ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones. Companies had a lower bar to clear coming into the ...